These final results, along with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,2 guidance the idea of targeting ACKR3 as a unique strategy to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Ailments. Researchers feel that blocking this https://wessexc935eyq0.theobloggers.com/profile